“Reinvigoration of antitumor immunity has recently become the central theme for the development of cancer therapies. Here the authors present an adaptable gene circuit to harness the CRISPRa for tumorlocalized immune activation.”
- Yafeng Wang
- Guiquan Zhang
- Jianghuai Liu
